Medical marijuana; disclosure of financial interest; requiring attestation; monitoring and disciplinary actions; certain inspections within certain time; grace periods; termination of license for failure to provide proof of business operations; effective date; emergency.
Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities.